IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome:Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (Study P04103)

This study is currently recruiting participants.
Information provided by Schering-Plough

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Hypercholesterolemia
			Myocardial Infarction
2		Additional conditions recognized in this trial
			Acute Coronary Syndrome
			Infarction
3		More general conditions related to this trial
			Cardiovascular Diseases
			Dyslipidemias
			Heart Diseases
			Hyperlipidemias
			Ischemia
			Lipid Metabolism Disorders
			Metabolic Diseases
			Myocardial Ischemia
			Necrosis
			Pathologic Processes
			Vascular Diseases
4		Interventions listed in this trial
			ezetimibe/simvastatin
			simvastatin
5		Additional drug interventions recognized in this trial
			Ezetimibe
6		More general drug interventions related to this trial
			Anticholesteremic Agents
			Antilipemic Agents
			Antimetabolites
			Enzyme Inhibitors
			Hydroxymethylglutaryl-CoA Reductase Inhibitors
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Therapeutic Uses
7		Sponsors listed in this trial
			Schering-Plough
			Merck